Given the ENHANCE trial results, ezetimibe is still unproven.
Taylor
Allen J
AJ
D001384:Azetidines / Q000494:pharmacology / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects* / Q000473:pathology; D019317:Evidence-Based Medicine; D000069438:Ezetimibe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D017539:Tunica Intima / Q000187:drug effects* / Q000473:pathology
D001384:Azetidines; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069438:Ezetimibe